RANK Mouse

RANK Mouse Recombinant
Shipped with Ice Packs
In Stock

Description

Definition and Genetic Basis of RANK Mouse Models

RANK Mouse refers to genetically modified murine models (e.g., knockouts, transgenics) used to study the RANK/RANKL pathway. Key genetic variants include:

ModelGenetic ModificationPrimary PhenotypeSource
RANK −/−Complete RANK deletionOsteopetrosis, absent lymph nodes
MMTV-RANK TransgenicMammary gland-specific RANK overexpressionHyperproliferation, impaired mammary differentiation
oim/oim + RANK-FcRANKL inhibition in osteogenesis imperfectaImproved bone density and stiffness

Osteoclast Differentiation and Bone Homeostasis

  • RANK −/− mice lack functional osteoclasts, leading to osteopetrosis (excessive bone density) and splenic B cell deficiency .

  • RANKL inhibition (via RANK-Fc) in oim/oim mice improved femoral cortical thickness (+18%) and stiffness (+25%) compared to saline-treated controls .

Immune and Lymphatic System Development

  • RANK deficiency abolishes peripheral lymph node formation but preserves mucosal-associated lymphoid tissue .

  • Dendritic cell (DC) differentiation and macrophage function remain intact in RANK −/− mice, indicating RANK’s specificity for osteoclast and lymph node pathways .

Pancreatic β Cell Survival

  • Cytokine-induced β cell death in mice and human islets requires RANK-TRAF6 interaction and NF-κB activation.

  • Denosumab (RANKL antibody) reduced β cell apoptosis by 40–60% in vitro and enhanced proliferation in transplanted human islets .

Mammary Gland Biology

  • MMTV-RANK transgenic mice showed RANKL-dependent mammary epithelial cell (MEC) proliferation and suppressed differentiation:

    • Ki-67 positivity: 100% in RANKL-treated MMTV-RANK acini vs. 30–50% in wild type .

    • Secretory function was impaired due to sustained proliferation .

Therapeutic Implications

InterventionEffectModelSource
Denosumab (DMB)Inhibits RANKL, reduces β cell deathHuman islets in mice
Osteoprotegerin (OPG)Blocks RANKL, improves bone biomechanicsoim/oim mice
TRAF6 inhibitorsSuppresses NF-κB, rescues β cell viabilityINS-1 cells, mouse islets

Rapid Assessment of Compound Exposure (RACE)

  • The RACE assay estimates drug exposure (eAUC<sub>20–120</sub>) in mice using a standardized protocol (n=4 mice, single dose) .

  • Simplifies pharmacokinetic profiling for RANK pathway inhibitors like Denosumab .

High-Diversity Mouse Populations

  • Collaborative Cross (CC) and Diversity Outbred (DO) mice capture 90% of Mus musculus genetic diversity, enabling nuanced RANK pathway analysis .

Table 1: RANK Signaling in β Cell Survival

Conditionβ Cell ViabilityNF-κB Activation
Cytokines + OPG↑ 60%↓ 70%
Cytokines + Denosumab↑ 55%↓ 65%
Cytokines + TRAF6 inhibitor↑ 75%↓ 85%
Data from primary mouse islets and human β cells .

Product Specs

Introduction
Tumor necrosis factor receptor superfamily member 11A, also known as TNFRSF11A or RANK, is a protein that belongs to the tumor necrosis factor receptor (TNFR) family. As the receptor for RANK-Ligand, RANK plays a crucial role in the activation and differentiation of osteoclasts. This protein is involved in various biological processes, including the activation of NF-kappa B and c-jun N-terminal kinase, stimulation of T cell growth, regulation of bone remodeling and repair, modulation of dendritic cell function, development of lymph nodes, regulation of immune cell function, development of mammary glands, and thermal regulation.
Description
Recombinant RANK Mouse, produced in Baculovirus, is a single glycosylated polypeptide chain comprising 426 amino acids (31-214 aa). With a molecular mass of 47.5kDa, it encompasses amino acids 31-214 of the RANK protein fused to a 242 amino acid hIgG-His-Tag at the C-terminus. Purification is achieved through proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered colorless solution.
Formulation
RANK protein is supplied at a concentration of 1mg/ml in a solution containing 10% glycerol and Phosphate-Buffered Saline (pH 7.4).
Stability
For short-term storage (2-4 weeks), store the solution at 4°C. For extended storage, freeze the solution at -20°C. It is advisable to add a carrier protein (0.1% HSA or BSA) for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
The purity of the protein is determined to be greater than 90.0% by SDS-PAGE analysis.
Synonyms

Tumor necrosis factor receptor superfamily member 11A, Osteoclast differentiation factor receptor, ODFR, Receptor activator of NF-KB, activator of NFKB, FEO, OFE, OSTS, PDB2, RANK, RANKLOH18CR1, CD265, CD265 antigen, OPTB7, TRANCER, LOH18CR1, receptor activator of nuclear factor-kappa B.

Source

Sf9, Baculovirus cells.

Amino Acid Sequence

ADLVTPPCTQ ERHYEHLGRC CSRCEPGKYL SSKCTPTSDS VCLPCGPDEY LDTWNEEDKC LLHKVCDAGK ALVAVDPGNH TAPRRCACTA GYHWNSDCEC CRRNTECAPG FGAQHPLQLN KDTVCTPCLL GFFSDVFSST DKCKPWTNCT LLGKLEAHQG TTESDVVCSS SMTLRRPPKE AQAYLPSLEP KSCDKTHTCP PCPAPELLGG PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSRDE LTKNQVSLTC LVKGFYPSDI VEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW QQGNVFSCSV MHEALHNHYT QKSLSLSPGK HHHHHH

Q&A

What is RANK Ligand and why is it important in mouse research models?

RANK Ligand (Receptor Activator of Nuclear Factor kappa-B Ligand) is a cell-bound marker related to the tumor necrosis factor (TNF) family of proteins. It plays a critical role in bone metabolism and osteoclast differentiation. In mouse models, RANK Ligand expression by T cells promotes dendritic cell maturation, making it an important molecule for studying both skeletal and immune system interactions . Mouse models using recombinant RANK Ligand have been instrumental in understanding bone diseases, immune disorders, and cancer metastasis processes.

How should I design reproducible experiments with RANK mouse models?

Reproducible RANK mouse research requires careful attention to experimental design principles. The Jackson Laboratory recommends several key strategies to enhance reproducibility:

  • Choose mouse strains wisely: Different strains have unique characteristics that affect RANK/RANKL expression and function

  • Calculate appropriate sample sizes based on power analyses to detect biologically relevant differences

  • Implement proper randomization and blinding procedures

  • Control for environmental variables that affect RANK/RANKL signaling

  • Standardize protocols for tissue collection, processing, and analysis

Additionally, follow the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) principles, which provide a framework for ethical animal use and promote robust experimental design. Remember that even genetically identical mice within a particular strain can show phenotypic variability, are sensitive to environmental factors, and change developmentally over time .

What are the key considerations when selecting mouse strains for RANK/RANKL studies?

Strain selection significantly influences experimental outcomes in RANK/RANKL research. Consider these factors:

  • C57BL/6J mice are widely used due to their well-characterized genome and immunological responses

  • Different strains develop age-related bone phenotypes at varying rates, affecting RANK/RANKL signaling interpretation

  • Genetic background effects on bone phenotype can mask or enhance RANK/RANKL-related outcomes

  • For transgenic and knockout studies, backcrossing to a consistent genetic background for at least 10 generations minimizes genetic variability

As The Jackson Laboratory notes, "Mouse strains are as variable as dog breeds, if not more so," making strain selection a critical experimental variable .

How should recombinant mouse RANK Ligand be prepared and handled for experiments?

Proper handling of recombinant mouse RANK Ligand is essential for experimental success:

  • Centrifuge the vial before opening

  • Reconstitute by gently pipetting the recommended solution down the sides of the vial

  • DO NOT VORTEX the solution

  • Allow several minutes for complete reconstitution

  • For prolonged storage, dilute to working aliquots in a 0.1% BSA solution

  • Store at -80°C and avoid repeated freeze-thaw cycles

Failure to follow these guidelines may result in loss of protein activity and experimental variability.

What methods are best for detecting and measuring RANK/RANKL expression in mouse tissues?

Multiple complementary techniques provide comprehensive assessment of RANK/RANKL expression:

  • Quantitative PCR (qPCR): Provides sensitive detection of mRNA expression with proper reference gene selection

  • Western Blotting: Confirms protein expression using validated antibodies specific to mouse RANK/RANKL

  • Immunohistochemistry: Provides spatial information on expression patterns with appropriate controls

  • Flow Cytometry: Enables quantification at the single-cell level, particularly useful for immune cell populations

  • ELISA: Quantifies soluble RANKL in serum or culture media

For optimal results, combine at least two of these approaches to verify expression at both mRNA and protein levels.

How can I effectively isolate and culture osteoclast precursors for RANK/RANKL studies?

The following protocol optimizes osteoclast precursor isolation and culture:

Isolation from bone marrow:

  • Harvest femurs and tibias from 6-12 week old mice

  • Flush bone marrow with cold PBS using a 25G needle

  • Culture in α-MEM with 10% FBS and M-CSF (25-50 ng/mL) for 3 days

  • Harvest non-adherent cells, which contain enriched osteoclast precursors

Culture conditions for osteoclastogenesis:

  • Base medium: α-MEM with 10% heat-inactivated FBS

  • Essential cytokines: M-CSF (25-50 ng/mL) and RANKL (50-100 ng/mL)

  • Plating density: 5×10⁴ cells/cm² for optimal fusion

  • Culture duration: 5-7 days for mature osteoclasts

  • Verification: TRAP staining and counting multinucleated (≥3 nuclei) TRAP+ cells

This approach typically yields approximately 2-3×10⁷ precursor cells per mouse.

How can I design preference testing experiments for enriched housing of laboratory mice?

The Mouse Positioning and Surveillance System (MoPSS) offers an effective approach for preference testing in laboratory mice. This system consists of:

  • Two interconnected cages with a connecting plexiglass tube

  • RFID antennas attached to the tube to track individual mouse movement

  • Plastic barriers within the tube to slow mouse movement and ensure RFID detection

For optimal experimental design:

  • House mice in groups of 4 animals to maintain normal social behavior

  • Use identical environmental conditions (light, temperature, humidity) for testing

  • Ensure equal light distribution using LED lighting aimed at the ceiling

  • Monitor light intensity with a lux meter to verify consistency

  • Equip both cages with standard bedding, shelter, nesting materials, and food/water

  • Conduct tests over 46 hours to capture both active and inactive phases

Analysis involves calculating stay times for each mouse in each cage, expressed as a percentage of the total testing period. This methodology allows assessment of individual and group preferences for different enrichment items.

What is the "worth value" calculation method for enrichment preference testing in mice?

The "worth value" calculation is an advanced statistical approach for ranking multiple enrichment items based on mouse preferences. This methodology:

  • Combines data from multiple binary choice tests where mice choose between different enrichment items

  • Calculates a relative preference score ("worth value") for each item

  • Normalizes these values across all tested items

  • Provides a hierarchical ranking of enrichment preferences

This approach is particularly valuable when categorizing enrichment items by their intended purpose:

  • Structural enrichment (physical cage organization)

  • Foraging enrichment (items stimulating natural food-seeking behaviors)

  • Housing enrichment (alternative resting locations)

The worth value method offers a more robust assessment than simple binary comparisons and accounts for individual variability in preference strength.

How do I distinguish between membrane-bound and soluble RANKL in mouse models?

Distinguishing between these RANKL forms is critical as they may have different biological activities:

Methodological approaches:

  • Differential centrifugation:

    • Sequential centrifugation separates membrane fractions containing membrane-bound RANKL

    • Ultracentrifugation (>100,000g) isolates membrane vesicles

    • Western blotting of fractions can confirm distribution

  • Flow cytometry:

    • Surface staining without permeabilization detects membrane-bound RANKL

    • Compare with permeabilized samples to assess total RANKL

    • Use fluorescence-minus-one controls for accurate gating

  • ELISA with sample preparation modifications:

    • Pretreatment of samples with detergents releases membrane-bound RANKL

    • Compare treated vs. untreated samples to quantify the membrane-bound fraction

  • Transgenic approaches:

    • Mouse models expressing only membrane-bound RANKL (deletion of cleavage site)

    • Conditional knockout models for tissue-specific expression analysis

What statistical approaches are most appropriate for analyzing RANK/RANKL-related phenotypes?

Statistical analysis should be tailored to the specific experimental design and data characteristics:

For comparing genotypes/treatments:

  • Two-group comparisons: t-test (parametric) or Mann-Whitney (non-parametric)

  • Multiple group comparisons: ANOVA with appropriate post-hoc tests

    • Tukey's test for all pairwise comparisons

    • Dunnett's test when comparing to a control group

  • Repeated measures designs: RM-ANOVA or mixed-effects models

Sample size considerations:

  • For gene expression studies: n=8-10 per group

  • For histomorphometry: n=6-8 per group

  • For serum biomarkers: n=10-12 per group

Reporting standards:

  • Include exact p-values rather than thresholds

  • Report effect sizes and confidence intervals

  • Present individual data points in addition to means/medians

  • Clearly state the statistical tests used and software version employed

How should I normalize RANK/RANKL expression data across different mouse tissues?

Normalization strategies should be tailored to the detection method and sample types:

For qPCR data:

  • Use multiple reference genes validated for stability across experimental conditions

  • Recommended reference gene combinations by tissue type:

    • Bone: Actb, Hprt1, and Tbp

    • Immune cells: Rpl13a, Ppia, and Gapdh

  • Apply geometric averaging of multiple reference genes

For protein quantification:

  • Western blotting: Normalize to total protein (Ponceau, REVERT) rather than single housekeeping proteins

  • ELISA: Express as concentration per unit protein or per tissue weight

  • Flow cytometry: Use median fluorescence intensity ratio to isotype control

For histological quantification:

  • Express as positive cells per defined area or tissue volume

  • Use stereological approaches for unbiased quantification

How can I analyze and interpret contradictory RANK/RANKL data in mouse studies?

Contradictory findings require systematic evaluation of multiple factors:

Strain-dependent effects:

  • C57BL/6 substrains may respond differently (J vs. N backgrounds)

  • BALB/c mice have different baseline bone turnover than C57BL/6

  • DBA/2 mice show heightened sensitivity to mechanical loading

Age and sex considerations:

  • Young mice (4-8 weeks): Rapid growth, high bone turnover

  • Adult mice (12-16 weeks): Stable bone mass, moderate turnover

  • Aged mice (>12 months): Age-related bone loss, altered RANKL sensitivity

  • Males vs. females: Estrogen modulates RANKL signaling

Methodological divergences:

  • Dose and duration of RANKL administration

  • Route of administration (local vs. systemic)

  • Protein source (commercial vendor, purification method)

  • Timing of measurements relative to intervention

Reconciliation strategies:

  • Direct replication studies with standardized protocols

  • Meta-analysis of multiple studies with moderator variables

  • Investigation of contextual factors (diet, housing, microbiome)

How do I address variability in RANK/RANKL expression between individual mice?

Biological variability in RANK/RANKL systems can be managed through several approaches:

Sources of variability:

  • Genetic: Even inbred strains show some variation

  • Environmental: Housing conditions, handling stress, microbiome

  • Developmental: Age, sex, reproductive status

  • Technical: Sample collection, processing, analysis methods

Experimental design strategies:

  • Increase sample size based on power calculations from preliminary data

  • Use paired designs where possible (e.g., contralateral limbs)

  • Block randomization by litter, cage, or initial body weight

  • Include baseline measurements as covariates in analysis

Standardization protocols:

  • Consistent time of day for sample collection (circadian effects)

  • Uniform fasting periods before blood collection

  • Standardized anesthesia protocols

  • Consistent tissue harvesting and processing times

What are potential causes of inconsistent results in enrichment preference testing?

When using systems like the Mouse Positioning and Surveillance System (MoPSS), several factors can lead to inconsistent results:

Technical considerations:

  • RFID antenna sensitivity and placement

  • Detector calibration and maintenance

  • Data logging system integrity

  • Proper functioning of plastic barriers in tunnels

Biological factors:

  • Individual mouse personality/temperament differences

  • Social hierarchy effects within groups

  • Previous enrichment exposure history

  • Age and sex of test subjects

Environmental variables:

  • Light intensity differences between cages

  • Airflow direction and intensity

  • External noises or vibrations

  • Temperature gradients

Analysis considerations:

  • Accounting for both active and inactive phases (full 46-hour analysis)

  • Distinguishing individual vs. group preferences

  • Proper statistical handling of missing data points

  • Appropriate normalization of time spent in transition zones

How can I design experiments to differentiate between direct and indirect effects of RANK/RANKL signaling?

Distinguishing direct from indirect effects requires specialized experimental approaches:

Cell-specific genetic models:

  • Cre-loxP systems with cell-specific promoters:

    • Lysozyme M-Cre for myeloid lineage

    • Cathepsin K-Cre for mature osteoclasts

    • Col1a1-Cre for osteoblasts

    • CD4-Cre for T lymphocytes

  • Tamoxifen-inducible systems to control timing of gene deletion

Ex vivo approaches:

  • Isolated cell cultures with defined conditions

  • Co-culture systems with different cell types separated by permeable membranes

  • Conditioned medium experiments to identify secreted factors

  • Cell-specific inhibitors or neutralizing antibodies

Bone marrow chimeras:

  • Irradiation and reconstitution with donor cells

  • Mixed chimeras with wild-type and mutant cells

  • Cell-specific tracking using congenic markers (CD45.1/CD45.2)

Molecular approaches:

  • Phosphorylation state analysis for direct signaling targets

  • Temporal gene expression analysis to establish sequence of events

  • ChIP-seq for identifying direct transcriptional targets

Product Science Overview

Structure and Expression

RANK is a type I transmembrane protein that is expressed on the surface of various cell types, including osteoclast precursors, dendritic cells, and mammary gland epithelial cells. The extracellular domain of RANK binds to its ligand, RANKL (Receptor Activator of Nuclear Factor Kappa-Β Ligand), which is also known as TRANCE, TNFSF11, or OPGL .

Function

The primary function of RANK is to mediate the effects of RANKL. When RANKL binds to RANK, it triggers a signaling cascade that leads to the activation of NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) and other downstream pathways. This signaling is essential for:

  1. Osteoclast Differentiation and Activation: RANK-RANKL interaction is critical for the formation, function, and survival of osteoclasts, the cells responsible for bone resorption. This process is vital for bone remodeling and calcium homeostasis .
  2. Immune System Regulation: RANK signaling influences the development and function of dendritic cells, which are key players in the immune response. It also affects the formation of lymph nodes and the maturation of mammary glands during pregnancy .
Recombinant RANK (Mouse)

Recombinant mouse RANK is produced using various expression systems, such as E. coli. The recombinant protein is typically purified to high levels of purity and is used in various research applications, including:

  • In Vitro Studies: To study the molecular mechanisms of RANK-RANKL interactions and their effects on osteoclastogenesis and immune cell functions.
  • Drug Development: As a target for developing therapeutic agents for diseases like osteoporosis, rheumatoid arthritis, and certain cancers .
Applications and Research

Recombinant mouse RANK is used extensively in research to understand its role in bone metabolism and immune regulation. It is also used to screen potential inhibitors that could be developed into drugs for treating bone-related diseases and immune disorders. The ability to produce recombinant RANK in a controlled environment allows researchers to conduct detailed studies on its structure, function, and interactions with other proteins .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.